Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer’s Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with

Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer’s Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European urology 2022-01, Vol.81 (1), p.e20-e21
Hauptverfasser: Shigeta, Keisuke, Matsumoto, Kazuhiro, Oya, Mototsugu
Format: Artikel
Sprache:eng
Schlagworte:
Carcinoma, Transitional Cell - drug therapy
Cohort Studies
Female
Humans
Male
Neoadjuvant Therapy
Urinary Bladder Neoplasms - pathology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e21
container_issue 1
container_start_page e20
container_title European urology
container_volume 81
creator Shigeta, Keisuke
Matsumoto, Kazuhiro
Oya, Mototsugu
description
doi_str_mv 10.1016/j.eururo.2021.10.008
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2590082934</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0302283821020765</els_id><sourcerecordid>2590082934</sourcerecordid><originalsourceid>FETCH-LOGICAL-e181t-eeec88c10de10af7b4133ee73e22073dacbf48a07ef670eb6f378d095b36ce703</originalsourceid><addsrcrecordid>eNptU01z0zAQNQwMlMI_YJg9cqgd2UpipweYNrRQmn5Mm5w9a2kdK7UtI8llwom_wd_jR3BGScowzHBa6c3b3bdvpSB4HbMoZvF4sIqoN73RUcKS2EMRY9njYC_OUh6mozF7EuwxzpIwyXj2PHhh7YoxxkcT_ix4zodpPGbDdO_Rrxvq6jU4DaeGpFF3MFMkCzLLA_isK2zhqDBYYWOtbg8AW7mDW7JwrIsVmZ_ff1iYkXNkNmVcRXAildMGDB3COSnb3xHcVmpJDg_gHL_1lTIaLtDZvtFOe0wrscWulqpC41nkAOsIPmjf5pI0ylV_j62DaUU-pSKD3RoqvCeYby_UOyXgmFoqlYPSN7_UksJOW-WUZy26zsubGxQOFmZToVZYwxSNUK1u8D3ckO1rZ0GXgHDhjyoU1G6GmupKGwe3rpfraJNdw1UrtJd31kJnyNoIKuc6ezgYSK0ibZaDv0vyG6p1K3ZbYmnEkskhHMF1TbjVuWiVDw3MyTReSq2X6y1-jU75_ha-Klf9V7Mfh9CR3DH-ceaYfAnyylurayVx68Ftb5Zk1lv6y-BpibWlVw9xP1icnsynn8LZ1cez6dEspDiLXUhEIstEzCTFDMu0GMacE6WckoSlXKIoymGGLKVynDIqxiVPM8kmo4KPBaWM7wdvd3U7o7_0ZF3eKCuorrEl3ds8GU38s00mfOipbx6ofdGQzDujGjTr_M9b9YR3OwJ5wfeKTG6Ft0iQVIaEy733eczyje_5Kt99jnxj-wb1Xfhv1GINJw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2590082934</pqid></control><display><type>article</type><title>Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer’s Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Shigeta, Keisuke ; Matsumoto, Kazuhiro ; Oya, Mototsugu</creator><creatorcontrib>Shigeta, Keisuke ; Matsumoto, Kazuhiro ; Oya, Mototsugu</creatorcontrib><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/j.eururo.2021.10.008</identifier><identifier>PMID: 34716047</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><subject>Carcinoma, Transitional Cell - drug therapy ; Cohort Studies ; Female ; Humans ; Male ; Neoadjuvant Therapy ; Urinary Bladder Neoplasms - pathology</subject><ispartof>European urology, 2022-01, Vol.81 (1), p.e20-e21</ispartof><rights>2021 European Association of Urology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-9222-0999</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.eururo.2021.10.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34716047$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shigeta, Keisuke</creatorcontrib><creatorcontrib>Matsumoto, Kazuhiro</creatorcontrib><creatorcontrib>Oya, Mototsugu</creatorcontrib><title>Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer’s Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with</title><title>European urology</title><addtitle>Eur Urol</addtitle><subject>Carcinoma, Transitional Cell - drug therapy</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Neoadjuvant Therapy</subject><subject>Urinary Bladder Neoplasms - pathology</subject><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptU01z0zAQNQwMlMI_YJg9cqgd2UpipweYNrRQmn5Mm5w9a2kdK7UtI8llwom_wd_jR3BGScowzHBa6c3b3bdvpSB4HbMoZvF4sIqoN73RUcKS2EMRY9njYC_OUh6mozF7EuwxzpIwyXj2PHhh7YoxxkcT_ix4zodpPGbDdO_Rrxvq6jU4DaeGpFF3MFMkCzLLA_isK2zhqDBYYWOtbg8AW7mDW7JwrIsVmZ_ff1iYkXNkNmVcRXAildMGDB3COSnb3xHcVmpJDg_gHL_1lTIaLtDZvtFOe0wrscWulqpC41nkAOsIPmjf5pI0ylV_j62DaUU-pSKD3RoqvCeYby_UOyXgmFoqlYPSN7_UksJOW-WUZy26zsubGxQOFmZToVZYwxSNUK1u8D3ckO1rZ0GXgHDhjyoU1G6GmupKGwe3rpfraJNdw1UrtJd31kJnyNoIKuc6ezgYSK0ibZaDv0vyG6p1K3ZbYmnEkskhHMF1TbjVuWiVDw3MyTReSq2X6y1-jU75_ha-Klf9V7Mfh9CR3DH-ceaYfAnyylurayVx68Ftb5Zk1lv6y-BpibWlVw9xP1icnsynn8LZ1cez6dEspDiLXUhEIstEzCTFDMu0GMacE6WckoSlXKIoymGGLKVynDIqxiVPM8kmo4KPBaWM7wdvd3U7o7_0ZF3eKCuorrEl3ds8GU38s00mfOipbx6ofdGQzDujGjTr_M9b9YR3OwJ5wfeKTG6Ft0iQVIaEy733eczyje_5Kt99jnxj-wb1Xfhv1GINJw</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Shigeta, Keisuke</creator><creator>Matsumoto, Kazuhiro</creator><creator>Oya, Mototsugu</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9222-0999</orcidid></search><sort><creationdate>202201</creationdate><title>Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer’s Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with</title><author>Shigeta, Keisuke ; Matsumoto, Kazuhiro ; Oya, Mototsugu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e181t-eeec88c10de10af7b4133ee73e22073dacbf48a07ef670eb6f378d095b36ce703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Carcinoma, Transitional Cell - drug therapy</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Neoadjuvant Therapy</topic><topic>Urinary Bladder Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shigeta, Keisuke</creatorcontrib><creatorcontrib>Matsumoto, Kazuhiro</creatorcontrib><creatorcontrib>Oya, Mototsugu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shigeta, Keisuke</au><au>Matsumoto, Kazuhiro</au><au>Oya, Mototsugu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer’s Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2022-01</date><risdate>2022</risdate><volume>81</volume><issue>1</issue><spage>e20</spage><epage>e21</epage><pages>e20-e21</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>34716047</pmid><doi>10.1016/j.eururo.2021.10.008</doi><orcidid>https://orcid.org/0000-0001-9222-0999</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0302-2838
ispartof European urology, 2022-01, Vol.81 (1), p.e20-e21
issn 0302-2838
1873-7560
language eng
recordid cdi_proquest_miscellaneous_2590082934
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Carcinoma, Transitional Cell - drug therapy
Cohort Studies
Female
Humans
Male
Neoadjuvant Therapy
Urinary Bladder Neoplasms - pathology
title Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer’s Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T08%3A09%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply%20to%20Fredrik%20Liedberg,%20Johan%20Abrahamsson,%20and%20Johannes%20Bobjer%E2%80%99s%20Letter%20to%20the%20Editor%20re:%20Keisuke%20Shigeta,%20Kazuhiro%20Matsumoto,%20Koichiro%20Ogihara,%20et%20al.%20Does%20Neoadjuvant%20Chemotherapy%20have%20Therapeutic%20Benefit%20for%20Node-positive%20Upper%20Tract%20Urothelial%20Carcinoma?%20Results%20of%20a%20Multi-center%20Cohort%20Study.%20Urol%20Oncol.%20In%20press.%20https://doi.org/10.1016/j.urolonc.2021.07.029:%20A%20Plea%20for%20Uniform%20Terminology%20for%20Patients%20with%20Urothelial%20Carcinoma%20Treated%20with%20Chemotherapy%20Before%20Consolidative%20Surgery%20with&rft.jtitle=European%20urology&rft.au=Shigeta,%20Keisuke&rft.date=2022-01&rft.volume=81&rft.issue=1&rft.spage=e20&rft.epage=e21&rft.pages=e20-e21&rft.issn=0302-2838&rft.eissn=1873-7560&rft_id=info:doi/10.1016/j.eururo.2021.10.008&rft_dat=%3Cproquest_pubme%3E2590082934%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2590082934&rft_id=info:pmid/34716047&rft_els_id=S0302283821020765&rfr_iscdi=true